Test bank for Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics, 8th Edition by Nader Rifai, PhD Chapters 1 - 49

Test bank for Tietz Fundamentals of Clinical Chemistry
c Y c Y c Y c Y c Y c Y c Y




and Molecular Diagnostics 8th
c Y Y
c c Y




c Y Edition by Nader Rifai, PhD Chapters
c Y Y
c c Y c Y c Y




c Y 1 - 49
c Y Y
c

,Y
c




TietzYFundamentals Yof YClinical YChemistry Yand YMolecularYDiagnostics Y8th Y Edition YTest
c c c c c c c c
c



c




Y Bank
c




Table Yof Ycontents: c c




I. YPrinciples YOfYLaboratory YMedicine
c c c c




Chapter Y1. YClinicalYChemistry, Y Molecular YDiagnostics, Yand YLaboratoryYMedicine
c c c c c c c c




Chapter Y2. YSelectionYand Y AnalyticalYEvaluation YofYMethods Y— YWithYStatisticalYTechniques
c c c c c c c c c c c




Chapter Y3. YClinicalYEvaluationYofYMethods
c c c c c




Chapter Y4. YEvidence-Based YLaboratoryYMedicine
c c c c




Chapter Y5. YEstablishment Y and YUse YofYReference YValues
c c c c c c c




Chapter Y6. YSpecimenYCollection, Y Processing, Yand Y Other YPreanalyticalYVariables
c c c c c c c c




Chapter Y7. YQualityYManagement c c c




II. YAnalytical YTechniquesYAnd YInstrumentation
c c c c




Chapter Y8. YPrinciples YofYBasic YTechniques Yand YLaboratoryYSafety
c c c c c c c c




Chapter Y9. YOpticalYTechniques c c c




Chapter Y10. YElectrochemistryYand YChemicalYSensors
c c c c c




Chapter Y11. YElectrophoresis c c




Chapter Y12. YChromatography c c




Chapter Y13. YMass YSpectrometry c c c




Chapter Y14.YEnzyme Yand YRate YAnalyses
c c c c c




Chapter Y15. YImmunochemicalYTechniques
c c c




Chapter Y16 YAutomation c c




Chapter Y17.YPoint-of-Care YInstrumentation
c c c




III. Y YAnalytes
c c




Chapter Y18. YAmino Y Acids, YPeptides, Yand YProteins
c c c c c c




Chapter Y19. YSerumYEnzymes c c c




Chapter Y20. YTumor YMarkers Yand YCancer YGenes
c c c c c c




Chapter Y21. YKidneyYFunction YTests Y— YCreatinine, YGFR, YUrea, Yand YUric YAcid
c c c c c c c c c c c




Chapter Y22. YCarbohydrates c c




Chapter Y23. YLipids, YLipoproteins, YApolipoproteins, Y and YOther YCardiac YRisk YFactors
c c c c c c c c c




Chapter Y24.YElectrolytes Yand YBlood YGases
c c c c c




Chapter Y25. YHormones c c




Chapter Y26. Y Catecholamines Yand YSerotonin
c c c c




Chapter Y27. Y YVitamins, YTraceYElements, YNutritional Y Assessment
c c c c c c c




Chapter Y28. YHemoglobin, YIron, Y and YBilirubin
c c c c c




Chapter Y29.YPorphyrins Yand YPorphyrias
c c c c




Chapter Y30. YTherapeutic YDrugs Yand YTheir YManagement
c c c c c c




Chapter Y31. YClinicalYToxicologyc c c




Chapter Y32. Y Toxic YMetals c c c




IV. Y YPathophysiology
c c




Chapter Y33. YDiabetes c c

,Chapter Y34. Y Cardiovascular YDisease
c c c




Chapter Y35. YKidneyYDisease
c c c




Chapter Y36. Y PhysiologyYand YDisordersYofYWater, YElectrolyte, Y and YAcid-Base YMetabolism
c c c c c c c c c c




Chapter Y37. Y YLiver YDisease
c c c c




Chapter Y38. Y Gastrointestinal Yand YPancreatic YDiseases
c c c c c




Chapter Y39. Y YDisorders YofYBone Yand YMineral YMetabolism
c c c c c c c c




Chapter Y40. Y YDisorders YofYthe YPituitaryYGland
c c c c c c c




Chapter Y41. Y DisordersYofYthe YAdrenal YCortex
c c c c c c




Chapter Y42. Y Thyroid YDisorders
c c c




Chapter Y43. Y Reproduction-Related YDisorders
c c c




Chapter Y44. Y YPregnancyYand YPrenatalYTesting
c c c c c c




Chapter Y45. Y Newborn YScreening Yand Y Inborn YErrors YofYMetabolism
c c c c c c c c




Chapter Y46. YPharmacogenetics
c c




V. Y YMolecular YDiagnostics
c c c




Chapter Y47. YPrinciples YofYMolecular YBiology
c c c c c




Chapter Y48. YNucleic Y Acid YTechniques Yand YApplications
c c c c c c




Chapter Y49. YGenomes Yand YNucleic YAcid YAlterations
c c c c c c

, TO YGET YALL YCHAPTERS YEMAIL YME YAT>>>>> Y Y Y
c c c c c c c c c




c Y
TO YGET YALL YCHAPTERS YEMAIL YME YAT>>>>> Y Y Y
c c c c c c c c c




c Y



ChapterY01: YClinical YChemistry, YMolecularYDiagnostics, YandYLaboratory YMedicine
c c c c c c c c




Y TestBank
c




MULTIPLE YCHOICE c




1. An Yindividual Yworking Yin Ya Yclinical YchemistryYlaboratoryYis Ymarried Yto Ya Ysales Yrepresentative
c c c c c c c c c c c c c




c who Yworks Yfor Ya YcompanyYthat Y sells Ychemistry YlaboratoryYsupplies. YWhen Ythe Ylaboratory
Y c c c c c c c c c c c c




cY manager Y requests Ya Ylist Y of Yneeded Ysupplies, Y cost Yof Ysupplies, Y and Yvendors, Ythis Y individual c c c c c c c c c c c c c




Yonly Y recommends Ythe Yspouse’sYcompanyYas Ythe Yvendor. YThis Y is Yconsidered Y to Ybe Ya(n):
c c c c c c c c c c c c c c




a. accounting Yissue. c




b. possible Yconflict Y ofYinterest. c c c




c. maintenance YofYconfidentialityYissue. c c c




d. problemYwith Yresource Yallocation. c c c




ANS: Y B c




ConcernYhas YbeenYraised Yover YtheYinterrelationships YbetweenYpractitioners Y inYthe Ymedical
c c c c c c c c c c c




Yfield Y and YcommercialYsuppliers Yof Ydrugs, Y devices, Y equipment, Y etc.,Yto Ythe Ymedical
c c c c c c c c c c c c




Yprofession.
c




Similarly, Yrelationships Yhave Ybeen Yscrutinized Y between Yclinical Ylaboratorians Yand
c c c c c c c c




cY manufacturers Yand Yproviders YofYdiagnostic Yequipment Y and Ysupplies. Y These Yconcerns Y led Ythe c c c c c c c c c c c




cY National YInstitutesYof YHealth Y(NIH) Yin Y1995 Yto Yrequire Yofficial YinstitutionalYreview Yof c c c c c c c c c c c c




Yfinancial Y disclosureYbyYresearchers Yand Y management Y ofYsituations Y inYwhich Ydisclosure
c c c c c c c c c c c




Yindicates Ypotential Y conflictsYof Yinterest.
c c c c c




DIF: 1 REF: Y Y YPageY4-5 c c c c OBJ: Y 6 Y |Y7 c c c




2. AYpatient Y visits Yher YphysicianYstating Ythat Y her Yprescribed Ypainkiller Y is Ynot Yworking Yto
c c c c c c c c c c c c c




creduce Y the Ypain Yfollowing Yher Yrecent Y surgery. Y A Yfriend YofYthe Ypatient Y claims Ythat Ythe
Y c c c c c c c c c c c c c c




Y
csame Ypainkiller Y “worked Ywonders” Yto Yreduce Yher YpainYafter Ythe Ysame Ysurgery. YThe
c c c c c c c c c c c c




Yphysician YstatesYthat Ythe Y difference Yin Ythe Yeffect Yof Ythe Ydrug Ymight Y be Ycaused Yby
c ,c c c c c c c c c c c c c c




Y which Yis Ystudied Y in Y pharmacogenetics.
c c c c c




a. epidemiology
b. anYinheritedYdisease c c




c. aYconflict YofYinterest c c c




d. aYgeneticYvariation YinYdrug-metabolizing Yenzymes
c c c c c




ANS: Y D c




Pharmacogenetics Yis YtheYstudyYofYtheYgenetic YvariationYofYdrugYmetabolism Ybetween c c c c c c c c c c c




cY individuals.



DIF: 1 REF: Y Y YPageY3 c c c c OBJ: Y 1 c




3. JohnYworks YinYa Y molecular Ydiagnostics YlaboratoryYand Yreceives Ya Yblood Ysample Ythat Y has Ythe
c c c c c c c c c c c c c c




c nameYofYa Yclose Yfriend Yprinted YonYthe Ybar-codedYlabel. YTheYgenetic YtestYthat Y isYordered
Y c c c c c c c c c c c c c c c




YonYthe Y friend’s Ysample Ywould Yprovide Ydiagnostic Y information Yabout Y a Ydisorder Ythat Yhas
c c c c c c c c c c c c c




Ya Ypoor Y prognosis, Y and Ythe Ytest Y is YusuallyYperformed Yby YJohn. Y He Yasks Ya Y fellow
c c c c c c c c c c c c c c c